BrainsWay’s revolutionary noninvasive treatment uses Deep Transcranial Magnetic Stimulation (dTMS) to safely and effectively target areas of the brain associated with MDD during 20 min treatment sessions — so you can live life to the fullest again.
“Now I have my energy - I can get out of bed and I can do the things that normal people don't struggle with.”
“I have battled with depression for years and the symptoms only got worse… BrainsWay Deep TMS saved my life.”
Watch What BrainsWay Patients Have to Say About Our Treatment
Studies have shown the treatment to be effective for patients with MDD who have failed to respond to or couldn’t tolerate medication. In real-life clinical settings, the treatment was proven to be effective for 3 out of 4 patients, with a 51% remission rate and a 75% response rate. BrainsWay’s unique treatment and personalized protocol can provide relief for your depression symptoms.
Why Choose BrainsWay Deep TMS?
BrainsWay Deep TMS has many advantages over other treatment options:
A noninvasive, FDA-Cleared treatment
Consists of short, 20-minute sessions
Generally well-tolerated, with no systemic side effects
Can significantly improve patients suffering from MDD
More than 1 in 2 patients with treatment-resistant depression achieved full remission
An outpatient procedure - no hospitalization or anesthesia
* Patients should consult with their doctor before undergoing Deep TMS. The most common side effects include temporary headaches and application site pain or discomfort, which generally dissipate after a few minutes. There is also a very rare risk of seizure associated with the treatment. Patients with metal in or around the head, such as in metal plates, implants and stents, should not undergo Deep TMS treatment.
* Deep TMS in Randomized, Controlled Trials: In the multicenter trial that led to FDA clearance of the Deep TMS device, 1 in 3 medication-resistant patients treated with Deep TMS achieved remission. In real-life community treatment settings, 20 sessions of Deep TMS produce remission rates even higher than those observed in clinical trials. Among patients who went on to complete a treatment course of 30 sessions, 1 in 2 achieved full remission. (Data on file)
If Antidepressants Aren’t Working For You, Speak to Your Doctor About BrainsWay Deep TMS for MDD Today
Over 15 million Americans suffer from depression. Approximately 40% of depression patients are resistant to current first-line SSRI medications.
Find out more about how BrainsWay MDD can help you!
BrainsWay's flagship technology, which is based on Deep Transcranial Magnetic Stimulation (TMS), launches a new era in brain disorder treatment. BrainsWay is dedicated to developing and providing advanced technology solutions for the treatment of a variety of brain disorders. The company was established in 2003.
BrainsWay’s treatment using Deep TMS is based on a strong patent portfolio including patents filed by the U.S. National Institutes of Health (NIH), and by the company. The company holds an exclusive license for the Deep TMS technology from the NIH.